Publicacións en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (20)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial

    International Journal of Cardiology, Vol. 391

2022

  1. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

  3. Role of vericiguat in the overall etiopathogenesis of heart failure with reduced ejection fraction. Current position

    Revista Espanola de Cardiologia Suplementos, Vol. 22, Núm. SB, pp. 8-14

  4. Thrombolysis by PLAT/tPA increases serum free IGF1 leading to a decrease of deleterious autophagy following brain ischemia

    Autophagy, Vol. 18, Núm. 6, pp. 1297-1317

  5. Vericiguat in heart failure: from scientific evidence to clinical practice

    Revista Clinica Espanola

2021

  1. Long-term prognosis of women with Brugada syndrome and electrophysiological study

    Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671

2020

  1. Reducing residual thrombotic risk in patients with peripheral artery disease: Impact of the COMPASS trial

    Drugs in Context, Vol. 9

  2. Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition

    Expert Review of Clinical Pharmacology, Vol. 13, Núm. 7, pp. 695-706

2018

  1. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm

    Europace, Vol. 20, Núm. 5, pp. 851-858

2017

  1. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

    Gastroenterology, Vol. 152, Núm. 6, pp. 1449-1461.e7

  2. The genetic component of bicuspid aortic valve and aortic dilation. An exome-wide association study

    Journal of Molecular and Cellular Cardiology, Vol. 102, pp. 3-9

2014

  1. Recomendaciones para una prescripción segura de antiinflamatorios no esteroideos: Documento de consenso elaborado por expertos nominados por 3 sociedades científicas (SER-SEC-AEG)

    Reumatologia Clinica, Vol. 10, Núm. 2, pp. 68-84

  2. Recomendaciones para una prescripción segura de antiinflamatorios no esteroideos: Documento de consenso elaborado por expertos nominados por 3 sociedades científicas (SER-SEC-AEG)

    Gastroenterologia y Hepatologia, Vol. 37, Núm. 3, pp. 107-127

2013

  1. Differential clinical characteristics and prognosis of intraventricular conduction defects in patients with chronic heart failure

    European Journal of Heart Failure, Vol. 15, Núm. 8, pp. 877-884

2010

  1. A comparative study of biomarkers for risk prediction in acute coronary syndrome-Results of the SIESTA (Systemic Inflammation Evaluation in non-ST-elevation Acute coronary syndrome) study

    Atherosclerosis, Vol. 212, Núm. 2, pp. 636-643

2008

  1. Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome

    Atherosclerosis, Vol. 201, Núm. 1, pp. 176-183

2007

  1. A multicentre, 12-week study of imidapril and candesartan cilexetil in patients with mild to moderate hypertension using ambulatory blood pressure monitoring

    Clinical Drug Investigation, Vol. 27, Núm. 6, pp. 407-417